Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats

[1]  M. Millan,et al.  S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.

[2]  James K Rilling,et al.  Neural correlates of maternal separation in rhesus monkeys , 2001, Biological Psychiatry.

[3]  N. Kalin,et al.  Emotion, plasticity, context, and regulation: perspectives from affective neuroscience. , 2000, Psychological bulletin.

[4]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[5]  P Videbech,et al.  PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review , 2000, Acta psychiatrica Scandinavica.

[6]  B. Jacobs,et al.  Electrical Stimulation of Rat Medial Prefrontal Cortex Enhances Forebrain Serotonin Output: Implications for Electroconvulsive Therapy and Transcranial Magnetic Stimulation in Depression , 1999, Neuropsychopharmacology.

[7]  L. Dawson,et al.  Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism , 1999, Neuropharmacology.

[8]  T. Koyama,et al.  Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. , 1999, European journal of pharmacology.

[9]  M. Thase,et al.  Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. , 1999, The American journal of psychiatry.

[10]  G. Aston-Jones,et al.  Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons , 1998, Neuroscience.

[11]  I. Lucki,et al.  Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test , 1998, Psychopharmacology.

[12]  M. Briley,et al.  Effects of Milnacipran and Pindolol on Extracellular Noradrenaline and Serotonin Levels in Guinea Pig Hypothalamus , 1997, Journal of neurochemistry.

[13]  J. Mann,et al.  The functional neuroanatomy of mood disorders. , 1997, Journal of psychiatric research.

[14]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[15]  S. Montgomery,et al.  Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability , 1997, International clinical psychopharmacology.

[16]  S. Kasper,et al.  Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results , 1996, International clinical psychopharmacology.

[17]  J. Guelfi,et al.  Milnacipran and selective serotonin reuptake inhibitors in major depression , 1996, International clinical psychopharmacology.

[18]  B. Leonard,et al.  Pharmacokinetics of milnacipran in comparison with other antidepressants , 1996, International clinical psychopharmacology.

[19]  Takeshi Inoue,et al.  Serotonergic activation reduces defensive freezing in the conditioned fear paradigm , 1996, Pharmacology Biochemistry and Behavior.

[20]  F. Borsini,et al.  Role of the serotonergic system in the forced swimming test , 1995, Neuroscience & Biobehavioral Reviews.

[21]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[22]  H. Bönisch,et al.  Cloning and expression of the bovine sodium‐ and chloride‐dependent noradrenaline transporter , 1994, FEBS letters.

[23]  R. Blakely,et al.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Takeshi Inoue,et al.  Effect of conditioned fear stress on serotonin metabolism in the rat brain , 1993, Pharmacology Biochemistry and Behavior.

[25]  F. Artigas,et al.  Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. , 1992, European journal of pharmacology.

[26]  M. Caron,et al.  Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.

[27]  Roberto Invernizzi,et al.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.

[28]  R. Tsujita,et al.  Cloning and expression of the human 5-HT1B-type receptor gene. , 1992, Biochemical and biophysical research communications.

[29]  Y. Itzhak,et al.  Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[30]  J. E. Sherman,et al.  Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats , 1988, Brain Research.

[31]  M. Fanselow,et al.  Conditional analgesia, defensive freezing, and benzodiazepines. , 1988, Behavioral neuroscience.

[32]  M. Briley,et al.  Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug , 1985, Neuropharmacology.

[33]  M. Fanselow,et al.  Conditional and unconditional components of post-shock freezing , 1980, The Pavlovian journal of biological science.

[34]  R. Porsolt,et al.  Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.

[35]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[36]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[37]  R. Wurtman,et al.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. , 1963, Biochemical pharmacology.

[38]  W. Drevets.  Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. , 2000, Progress in brain research.

[39]  M. Briley,et al.  Antidepressant Properties of Specific Serotonin—Noradrenaline Reuptake Inhibitors , 1997 .

[40]  M. Ansseau,et al.  Pilot study of milnacipran in panic disorder , 1991, European Psychiatry.

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .